Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for National Research Corporation (NRC:NASDAQ), powered by AI.
National Research Corporation is currently trading at $18.47. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for National Research Corporation on Alpha Lenz.
National Research Corporation's P/E ratio is 35.6.
“National Research Corporation trades at a P/E of 35.6 (premium valuation) with strong ROE of 51.2%.”
Ask for details →National Research Corporation is a prominent organization specializing in healthcare data analytics and insights. Its primary function is to provide comprehensive survey-based analytics and tools that support healthcare systems, medical practices, and businesses in understanding patient experiences and improving care quality. National Research Corporation plays a vital role in the healthcare industry by delivering actionable intelligence that influences how healthcare providers engage with patients and foster improvement across various healthcare delivery areas. The company's services extend across numerous healthcare sectors, including hospitals, health plans, and post-acute care services. National Research Corporation is integral to refining strategies for patient engagement, clinical outcomes, and operational efficiency. Its reputation is built on empowering healthcare organizations with reliable data and insights, aiding these institutions in navigating the complexities of patient-centered care amidst evolving industry standards and regulations. Through its diverse range of products, the corporation remains essential to the transformation and improvement of patient care and satisfaction within the healthcare market.
“National Research Corporation trades at a P/E of 35.6 (premium valuation) with strong ROE of 51.2%.”
Ask for details →National Research Corporation (ticker: NRC) is a company listed on NASDAQ in the Healthcare sector (Health Information Services). It has approximately 368 employees. Market cap is $413M.
The current price is $18.47 with a P/E ratio of 35.64x and P/B of 29.55x.
ROE is 51.24% and operating margin is 16.44%. Annual revenue is $137M.